Date | Event | Description |
---|---|---|
6 February 2018 | Review declared as stable | This review question is broad and no longer reflects the clinical management of breast cancer. Today, chemotherapy decisions are based on the molecular subtype of the breast cancer. As the trials in this Review include women diagnosed with unselected metastatic breast cancer, this Review will no longer be updated. |